Record number of STDs, COVID-19 antibody cocktail
April 20, 2021
1 min read
The CDC announced a record number of cases of chlamydia, gonorrhea and syphilis in the United States in 2019. It was the first history of infectious diseases last week.
Report found significantly higher rates of STDs in gay and bisexual men than in heterosexual men, African Americans or Blacks, Native Americans or Alaskan Indians, and Indians from Hawaii or other islands. Pacific versus non-Hispanic whites.
In addition, researchers in a phase 3 trial have found that a subcutaneous injection of the cocktail of REGEN-COV antibodies (Regeneron) significantly reduced the risk of symptomatic COVID-19 in household contacts of infected individuals. REGEN-COV was 72% effective in protecting household contacts the first week and 93% the following weeks, according to a press release. Protection was 81% over 29 days.
Read these and other infectious disease articles below:
US reports record number of STDs for 6th year in a row
The United States reported more than 2.5 million cases of chlamydia, gonorrhea and syphilis in 2019, setting a record for STDs for the sixth consecutive year, the CDC said. Read more.
Subcutaneous injection of an antibody cocktail reduces the risk of symptomatic SARS-CoV-2
Subcutaneous injection of REGEN-COV – a combination of two monoclonal antibodies – reduced the risk of symptomatic SARS-CoV-2 infection by more than 80% among household contacts of those infected, Regeneron said. Read more.
Q&A: What is collective immunity and what will happen to SARS-CoV-2 if we achieve it?
In recent comments regarding COVID-19, director of the National Institute of Allergy and Infectious Diseases and Chief Presidential Medical Advisor Anthony S. Fauci, MD, called the concept of collective immunity an âelusive numberâ. Read more.
CDC, FDA recommend halting J&J vaccine rollout on six blood clots case
Federal health officials have recommended that the United States “suspend” the deployment of Johnson & Johnson’s COVID-19 vaccine so that experts can examine six reported cases of a rare but serious type of blood clot in people with received the vaccine. Read more.
CDC advisory group says it needs more information on J&J vaccine
A CDC advisory committee said it needed more information before it could decide to change its recommendation for Johnson & Johnson’s COVID-19 vaccine. Read more.